Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $72.85 USD
Change Today 0.00 / 0.00%
Volume 0.0
SHPGF On Other Exchanges
Symbol
Exchange
SHPGF is not on other exchanges.
As of 8:10 PM 08/26/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by SHIRE PLC (SHPGF) in the last 6 months

Announced 08/4/15
30.91B for Baxalta Incorporated
Merger/Acquisition

Shire plc (LSE:SHP) made an offer to acquire Baxalta Incorporated (NYSE:BXLT) from Baxter International Inc. (NYSE:BAX), BlackRock, Inc. (NYSE:BLK) and others for approximately $30 billion in stock on July 10, 2015. As part of consideration, Shire offered 0.1687 ADR shares for each share of Baxalta. As a result of transaction, Baxalta's shareholders will hold approximately 37% in the Shire. Shire will repurchase up to 13% of the combined post-transaction shares in two ...
Read More


SHPGF's price was unchanged after the transaction was announced on 08/4/15.
Investor / Buyer
Shire plc
Creditor / Lender
Baxter International Inc.
BlackRock, Inc.
 
Announced 08/3/15
300.00M for Foresight Biotherapeutics, Inc.
Merger/Acquisition

Shire plc (LSE:SHP) agreed to acquire Foresight Biotherapeutics, Inc. for approximately $300 million in cash on August 3, 2015.The deal is subject to regulatory approval. Steven Navarro, Phoebe Mounts, Lou Beardell, Harry Robins, Randall McGeorge, Bryan Keighery, Lydia Lee, Morgan McDevitt, Squire Servance and David Brenneman of Morgan Lewis acted as legal advisor to Foresight Biotherapeutics. William J. Chudd, Cheryl Chan, Andrew D. Krause, Martin Hui, Michael Mollerus, ...
Read More


SHPGF's price was unchanged after the transaction was announced on 08/3/15.
Investor / Buyer
Shire plc
Legal Advisor
Morgan, Lewis & Bockius LLP
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHPGF:US $72.85 USD 0.00

SHPGF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CSL Ltd A$92.62 AUD -0.13
Eisai Co Ltd ¥8,045 JPY +331.00
Hospira Inc $89.92 USD 0.00
Mylan NV $50.51 USD -0.98
Perrigo Co PLC $186.30 USD -1.89
View Industry Companies
 

Industry Analysis

SHPGF

Industry Average

Valuation SHPGF Industry Range
Price/Earnings 14.1x
Price/Sales 7.0x
Price/Book 4.7x
Price/Cash Flow 13.5x
TEV/Sales 7.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.